Summary of Classification and Labelling
General Information
EC / List no.
|
Name |
CAS Number
|
|---|---|---|
| 692-054-2 | (2S)-4-methyl-N-[(2S)-1-[[(2S)-4-methyl-1-[(2R)-2-methyloxiran-2-yl]-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]-2-[[(2S)-2-[(2-morpholin-4-ylacetyl)amino]-4-phenylbutanoyl]amino]pentanamide | 868540-17-4 |
Notified classification and labelling according to CLP criteria
| Classification | Labelling | Specific Concentration limits, M-Factors | Notes | Classification affected by Impurities / Additives
|
Additional Notified Information
|
Number of Notifiers
|
Joint Entries
|
||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Hazard Class and Category Code(s) | Hazard Statement Code(s) | Hazard Statement Code(s) | Supplementary Hazard Statement Code(s) | Pictograms, Signal Word Code(s) | |||||||
| Skin Irrit. 2 | H315 | H315 |
GHS08 GHS07 Dgr |
State/Form
|
2 | View details | |||||
| Eye Irrit. 2 | H319 | H319 | |||||||||
| Repr. 2 | H361 (H361fd Suspecte...) | H361 (fd) | |||||||||
| STOT RE 1 | H372 (not known) | H372 | |||||||||
| H361 |
GHS01 Dgr |
State/Form
|
1 | View details | |||||||
| STOT RE 1 | H372 (other:Cardiovas...) | H372 | |||||||||
| H413 | |||||||||||
| Acute Tox. 4 | H302 | H302 |
GHS07 Wng |
1 | View details | ||||||
| Skin Irrit. 2 | H315 | H315 | |||||||||
| Eye Irrit. 2 | H319 | H319 | |||||||||
| STOT SE 3 | H335 (inhalation) | H335 | |||||||||
| Acute Tox. 1 | H300 | H300 |
GHS07 GHS06 Dgr |
State/Form
|
1 | View details | |||||
| STOT SE 3 | H335 (vascular system) (inhalation) | H335 | |||||||||
| Acute Tox. 4 | H302 | H302 |
GHS07 Wng |
State/Form
|
1 | View details | |||||
| Skin Irrit. 2 | H315 | H315 | |||||||||
| Eye Irrit. 2 | H319 | H319 | |||||||||
| STOT SE 3 | H335 (alveolar duct) | H335 | |||||||||
Number of Aggregated Notifications: 5